A phase 2 evaluation of irofulven as second-line treatment of recurrent or persistent intermediately platinum-sensitive ovarian or primary peritoneal cancer: A gynecologic oncology group trial

Russell J. Schilder, John A. Blessing, Mark S. Shahin, David S. Miller, Krishnansu Sujata Tewari, Carolyn Y. Muller, David P. Warshal, Scott McMeekin, Jacob Rotmensch

Research output: Contribution to journalArticle

6 Scopus citations
Original languageEnglish (US)
Number of pages1
JournalInternational Journal of Gynecological Cancer
Volume20
Issue number7
DOIs
StatePublished - Oct 2010

Keywords

  • GOG
  • Irofulven
  • Platinum-sensitive ovarian cancer
  • Primary peritoneal cancer

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'A phase 2 evaluation of irofulven as second-line treatment of recurrent or persistent intermediately platinum-sensitive ovarian or primary peritoneal cancer: A gynecologic oncology group trial'. Together they form a unique fingerprint.

  • Cite this